中国实用医药
中國實用醫藥
중국실용의약
CHINA PRACTICAL MEDICAL
2015年
3期
4-5
,共2页
王东辉%杜娟%高寒%胡曼丽%田小海
王東輝%杜娟%高寒%鬍曼麗%田小海
왕동휘%두연%고한%호만려%전소해
阿法骨化醇%全段甲状旁腺激素%维持性血液透析
阿法骨化醇%全段甲狀徬腺激素%維持性血液透析
아법골화순%전단갑상방선격소%유지성혈액투석
Alfacalcidol%Intact parathyroid hormone%Maintenance hemodialysis
目的:观察阿法骨化醇对维持性血液透析患者甲状旁腺激素(iPTH)的影响,并探讨其临床意义。方法24例慢性肾衰竭尿毒症期行维持性血液透析治疗6个月以上患者作为血液透析组(HD组),同期体检健康人群22例作为健康对照组(Con组)。治疗开始HD组患者口服阿法骨化醇,1μg/d,元素钙2000 mg。共观察12周。Con组患者及HD组患者用药前后均查肾功能及血电解质,用放免法检测iPTH和骨钙素(BGP)。结果用药前HD组与Con组比较, iPTH, BGP及血肌酐(Cre)明显升高,血钙(Ca)降低,血磷(P)升高,差异有统计学意义(P<0.05)。用药后HD组iPTH和BGP明显下降,血钙升高,差异有统计学意义(P<0.05)。结论补充阿法骨化醇,可以降低维持性血液透析患者血清iPTH水平,进而改善肾性骨病,为临床治疗提供了新思路。
目的:觀察阿法骨化醇對維持性血液透析患者甲狀徬腺激素(iPTH)的影響,併探討其臨床意義。方法24例慢性腎衰竭尿毒癥期行維持性血液透析治療6箇月以上患者作為血液透析組(HD組),同期體檢健康人群22例作為健康對照組(Con組)。治療開始HD組患者口服阿法骨化醇,1μg/d,元素鈣2000 mg。共觀察12週。Con組患者及HD組患者用藥前後均查腎功能及血電解質,用放免法檢測iPTH和骨鈣素(BGP)。結果用藥前HD組與Con組比較, iPTH, BGP及血肌酐(Cre)明顯升高,血鈣(Ca)降低,血燐(P)升高,差異有統計學意義(P<0.05)。用藥後HD組iPTH和BGP明顯下降,血鈣升高,差異有統計學意義(P<0.05)。結論補充阿法骨化醇,可以降低維持性血液透析患者血清iPTH水平,進而改善腎性骨病,為臨床治療提供瞭新思路。
목적:관찰아법골화순대유지성혈액투석환자갑상방선격소(iPTH)적영향,병탐토기림상의의。방법24례만성신쇠갈뇨독증기행유지성혈액투석치료6개월이상환자작위혈액투석조(HD조),동기체검건강인군22례작위건강대조조(Con조)。치료개시HD조환자구복아법골화순,1μg/d,원소개2000 mg。공관찰12주。Con조환자급HD조환자용약전후균사신공능급혈전해질,용방면법검측iPTH화골개소(BGP)。결과용약전HD조여Con조비교, iPTH, BGP급혈기항(Cre)명현승고,혈개(Ca)강저,혈린(P)승고,차이유통계학의의(P<0.05)。용약후HD조iPTH화BGP명현하강,혈개승고,차이유통계학의의(P<0.05)。결론보충아법골화순,가이강저유지성혈액투석환자혈청iPTH수평,진이개선신성골병,위림상치료제공료신사로。
Objective To observe the influence of alfacalcidol on intact parathyroid hormone (iPTH) in maintenance hemodialysis patients, and to investigate its clinical significance.Methods Hemodialysis group (HD group) contained 24 patients with maintenance hemodialysis of chronic renal failure uremia for more than 6 months, and health control group (Con group) contained 22 health people in the same time period. HD group received 1μg/d of alfacalcidol and 2000 mg of calcium through oral administration. The observation lasted for 12 weeks. The renal function and blood electrolytes were detected in the two groups before and after treatment. Intact parathyroid hormone and bone gla protein (BGP) were detected by radioimmunoassay method.Results HD group had higher iPTH, BGP and serum creatinine (Cre), decreased blood calcium (Ca), and increased serum phosphate (P) than the Con group before treatment. The difference had statistical significance (P<0.05). The iPTH and BGP decreased and blood calcium increased in HG group after treatment, and the difference had statistical significance (P<0.05).Conclusion Supplement of alfacalcidol can reduce iPTH level in maintenance hemodialysis patients, therefore their renal osteopathy can be improved. This method provides a new idea for clinical treatment.